ArticleEClinicalMedicine2019

Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE-Results from the ExACT randomised controlled trial.

Charlotte Bradbury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.